Table 1 Patient characteristics in a prospective observational study (N = 51)
Characteristics | N = 51 | % |
|---|---|---|
Age, median (range) | 68 (36–81) | |
Sex (Male/Female) | 28/23 | 55/45 |
Smoking (Yes/No) | 25/26 | 49/51 |
EGFR mutation (19del/L858R/others) | 32/13/6 | 63/25/22 |
Stage at the diagnosis (III/IV/postoperative recurence) | 1/45/5 | 2/88/10 |
Performance status | ||
0–1/2 | 45/6 | 88/12 |
Treatment line with afatinib | ||
First-line | 39 | 76 |
Second or subsequent | 12 | 24 |